125 related articles for article (PubMed ID: 8882961)
1. Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.
Vacca A; Ribatti D; Fanelli M; Costantino F; Nico B; Di Stefano R; Serio G; Dammacco F
Leuk Lymphoma; 1996 Aug; 22(5-6):473-81. PubMed ID: 8882961
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study.
Ribatti D; Vacca A; Nico B; Fanelli M; Roncali L; Dammacco F
Eur J Haematol; 1996; 56(1-2):45-53. PubMed ID: 8599993
[TBL] [Abstract][Full Text] [Related]
3. Determination of vascularization of B-cell non-Hodgkin's lymphomas with four markers.
Vacca A; Ribatti D; Gasparini G; Fanelli M; Minischetti M; Ritelli G; Costantino F; Iurlaro M; Bonoldi E; Dammacco F
Int J Oncol; 1996 Mar; 8(3):561-6. PubMed ID: 21544397
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas.
Vacca A; Ribatti D; Ruco L; Giacchetta F; Nico B; Quondamatteo F; Ria R; Iurlaro M; Dammacco F
Br J Cancer; 1999 Feb; 79(5-6):965-70. PubMed ID: 10070898
[TBL] [Abstract][Full Text] [Related]
5. Tenascin in reactive lymph nodes and in malignant lymphomas.
Soini Y; Alavaikko M; Lehto VP; Virtanen I
Pathol Res Pract; 1992 Dec; 188(8):1078-82. PubMed ID: 1284450
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Olsen ML; Funder AM; d'Amore F
Leuk Lymphoma; 2007 Mar; 48(3):584-95. PubMed ID: 17454603
[TBL] [Abstract][Full Text] [Related]
7. B-cell non-Hodgkin's lymphomas express heterogeneous patterns of neovascularization.
Crivellato E; Nico B; Vacca A; Ribatti D
Haematologica; 2003 Jun; 88(6):671-8. PubMed ID: 12801843
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies.
Vacca A; Ribatti D; Roncali L; Dammacco F
Leuk Lymphoma; 1995 Dec; 20(1-2):27-38. PubMed ID: 8750620
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma.
Mazur G; Wróbel T; Dziegiel P; Jeleń M; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2004; 42(4):241-3. PubMed ID: 15704651
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas.
Ribatti D; Vacca A; Marzullo A; Nico B; Ria R; Roncali L; Dammacco F
Int J Cancer; 2000 Jan; 85(2):171-5. PubMed ID: 10629073
[TBL] [Abstract][Full Text] [Related]
11. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes.
Wróel T; Mazur G; Dziegiel P; Jeleń M; Szuba A; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2006; 44(1):43-7. PubMed ID: 16584091
[TBL] [Abstract][Full Text] [Related]
12. Vascular density (tumor angiogenesis) in non-Hodgkin's lymphomas and florid follicular hyperplasia: a morphometric study.
Arias V; Soares FA
Leuk Lymphoma; 2000 Dec; 40(1-2):157-66. PubMed ID: 11426617
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
[TBL] [Abstract][Full Text] [Related]
14. Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma.
Passalidou E; Stewart M; Trivella M; Steers G; Pillai G; Dogan A; Leigh I; Hatton C; Harris A; Gatter K; Pezzella F
Br J Cancer; 2003 Feb; 88(4):553-9. PubMed ID: 12592369
[TBL] [Abstract][Full Text] [Related]
15. Basement membrane components in lymphoid follicles: immunohistochemical demonstration and relationship to the follicular dendritic cell network.
Gloghini A; Colombatti A; Bressan G; Carbone A
Hum Pathol; 1989 Oct; 20(10):1001-7. PubMed ID: 2676838
[TBL] [Abstract][Full Text] [Related]
16. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin D2 and D3 in lymphoid lesions.
Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
[TBL] [Abstract][Full Text] [Related]
18. Mast cell heterogeneity in B-cell non-Hodgkin's lymphomas: an ultrastructural study.
Crivellato E; Nico B; Vacca A; Dammacco F; Rebatti D
Leuk Lymphoma; 2002 Nov; 43(11):2201-5. PubMed ID: 12533047
[TBL] [Abstract][Full Text] [Related]
19. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.
Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S
Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718
[TBL] [Abstract][Full Text] [Related]
20. Distribution of extracellular matrix components and their receptors in human lymphoid tissue and B-cell non-Hodgkin lymphomas.
Jaspars LH; Bloemena E; Bonnet P; Van der Valk P; Meijer CJ
Histopathology; 1995 Feb; 26(2):113-21. PubMed ID: 7537715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
